Nuveen Asset Management, LLC Alaunos Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $1.15 Million - $3.47 Million	-2,794,428 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.62 - $1.17 $470,296 - $887,495	758,543 Added 37.26%	2,794,428 $2.04 Million
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $880,919 - $1.53 Million	808,183 Added 65.83%	2,035,885 $2.3 Million
Q3 2021 Nov 12, 2021	BUY	$1.44 - $2.73 $7,116 - $13,491	4,942 Added 0.4%	1,227,702 $2.24 Million
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $917,417 - $1.28 Million	348,828 Added 39.91%	1,222,760 $3.23 Million
Q1 2021 May 17, 2021	SELL	$2.82 - $5.6 $56,772 - $112,739	-20,132 Reduced 2.25%	873,932 $3.15 Million
Q4 2020 Feb 16, 2021	SELL	$2.09 - $3.09 $211,535 - $312,748	-101,213 Reduced 10.17%	894,064 $2.25 Million
Q3 2020 Nov 16, 2020	SELL	$2.39 - $3.43 $174,883 - $250,983	-73,173 Reduced 6.85%	995,277 $2.51 Million
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $566,671 - $955,614	257,578 Added 31.77%	1,068,450 $3.51 Million
Q1 2020 May 14, 2020	BUY	$1.9 - $4.98 $157,903 - $413,872	83,107 Added 11.42%	810,872 $1.99 Million
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $31,035 - $42,034	-7,857 Reduced 1.07%	727,765 $3.44 Million
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $168,739 - $283,547	40,857 Added 5.88%	735,622 $3.15 Million
Q2 2019 Aug 15, 2019	BUY	$3.98 - $6.2 $2.77 Million - $4.31 Million	694,765 New	694,765 $4.05 Million

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $422M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.